BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8846957)

  • 21. Screening for Tay-Sachs disease.
    Int J Gynaecol Obstet; 1996 Mar; 52(3):311-2. PubMed ID: 8775693
    [No Abstract]   [Full Text] [Related]  

  • 22. Computer assisted small-scale Tay-Sachs carrier screening.
    Toney JH; Quirk JM
    J Appl Biochem; 1983; 5(1-2):25-30. PubMed ID: 6236193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A G to C transversion in codon 258 of the alpha-subunit of beta-hexosaminidase A in an infant Tay-Sachs disease patient.
    Brewer KK
    Hum Mutat; 1993; 2(6):496-7. PubMed ID: 8111418
    [No Abstract]   [Full Text] [Related]  

  • 24. Carrier screening for Tay-Sachs.
    Ellis I
    Nursing (Lond); 1991 Sep 12-25; 4(41):16-8. PubMed ID: 1945106
    [No Abstract]   [Full Text] [Related]  

  • 25. Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.
    Navon R; Proia RL
    Am J Hum Genet; 1991 Feb; 48(2):412-9. PubMed ID: 1825014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of three alpha-chain beta-hexosaminidase A mutations among Tay-Sachs carriers.
    Grebner EE; Tomczak J
    Am J Hum Genet; 1991 Mar; 48(3):604-7. PubMed ID: 1825595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis.
    Mahuran DJ
    Biochim Biophys Acta; 1991 Feb; 1096(2):87-94. PubMed ID: 1825792
    [No Abstract]   [Full Text] [Related]  

  • 28. Community-based genetic education: sources of information in a Tay Sachs disease screening program.
    Clark M; Palmer R; Kontras S
    Ohio State Med J; 1982 Mar; 78(3):218-20. PubMed ID: 7078924
    [No Abstract]   [Full Text] [Related]  

  • 29. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
    Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
    Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor splice site mutation in intron 5 of the HEXA gene in a Turkish infant with Tay-Sachs disease.
    Ozkara HA; Akerman BR; Ciliv G; Topçu M; Renda Y; Gravel RA
    Hum Mutat; 1995; 5(2):186-7. PubMed ID: 7749419
    [No Abstract]   [Full Text] [Related]  

  • 31. Tay-Sachs disease screening and diagnosis: evolving technologies.
    Hechtman P; Kaplan F
    DNA Cell Biol; 1993 Oct; 12(8):651-65. PubMed ID: 8397824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ovrselling of genetic anxiety.
    Goodman MJ; Goodman LE
    Hastings Cent Rep; 1982 Oct; 12(5):20-7. PubMed ID: 7174291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular basis of Tay-Sachs disease: mutation identification and diagnosis.
    Mahuran DJ; Triggs-Raine BL; Feigenbaum AJ; Gravel RA
    Clin Biochem; 1990 Oct; 23(5):409-15. PubMed ID: 2147596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view.
    Edelson PJ
    Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemistry and genetics of Tay-Sachs disease.
    Gravel RA; Triggs-Raine BL; Mahuran DJ
    Can J Neurol Sci; 1991 Aug; 18(3 Suppl):419-23. PubMed ID: 1834320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chronic GM2 gangliosidosis variant with a HEXA splicing defect: quantitation of HEXA mRNAs in normal and mutant fibroblasts.
    Fernandes MJ; Hechtman P; Boulay B; Kaplan F
    Eur J Hum Genet; 1997; 5(3):129-36. PubMed ID: 9272736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model.
    Kaback MM
    Eur J Pediatr; 2000 Dec; 159 Suppl 3():S192-5. PubMed ID: 11216898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal diagnosis of a Japanese family at risk for Tay-Sachs disease. Application of a fluorescent competitive allele-specific polymerase chain reaction (PCR) method.
    Tamasu S; Nishio H; Ayaki H; Lee MJ; Mizutori M; Takeshima Y; Nakamura H; Matsuo M; Maruo T; Sumino K
    Kobe J Med Sci; 1999 Dec; 45(6):259-70. PubMed ID: 10985159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplexed fluorescence analysis for mutations causing Tay-Sachs disease.
    Stockley TL; Ray PN
    Methods Mol Biol; 2003; 217():131-41. PubMed ID: 12491928
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular basis of heat labile hexosaminidase B among Jews and Arabs.
    Narkis G; Adam A; Jaber L; Pennybacker M; Proia RL; Navon R
    Hum Mutat; 1997; 10(6):424-9. PubMed ID: 9401004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.